Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Homo sapiens | nuclear factor, erythroid 2-like 2 | Starlite/ChEMBL | No references |
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | heat shock protein HSP90 | 0.007 | 0.2336 | 1 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 0.6566 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.1515 | 0.1515 |
Trypanosoma cruzi | heat shock protein 85, putative | 0.007 | 0.2336 | 1 |
Trypanosoma cruzi | heat shock protein 85, putative | 0.007 | 0.2336 | 1 |
Schistosoma mansoni | endoplasmin | 0.007 | 0.2336 | 0.2336 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0846 | 0.362 |
Mycobacterium leprae | PROBABLE CHAPERONE PROTEIN HTPG (HEAT SHOCK PROTEIN) (HSP90 FAMILY PROTEIN) (HIGH TEMPERATURE PROTEIN G) | 0.0055 | 0.153 | 0.5 |
Trypanosoma brucei | heat shock protein 90, putative | 0.007 | 0.2336 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0043 | 0.0846 | 0.0846 |
Entamoeba histolytica | heat shock protein 90, putative | 0.007 | 0.2336 | 1 |
Trypanosoma cruzi | Heat shock protein 83, putative | 0.007 | 0.2336 | 1 |
Loa Loa (eye worm) | endoplasmin | 0.007 | 0.2336 | 0.3558 |
Trypanosoma brucei | heat shock protein, putative | 0.007 | 0.2336 | 1 |
Plasmodium vivax | heat shock protein 86, putative | 0.007 | 0.2336 | 1 |
Trichomonas vaginalis | heat shock protein, putative | 0.007 | 0.2336 | 1 |
Schistosoma mansoni | endoplasmin | 0.007 | 0.2336 | 0.2336 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.1515 | 0.1515 |
Trypanosoma brucei | heat shock protein, putative | 0.007 | 0.2336 | 1 |
Echinococcus granulosus | heat shock protein 90 | 0.0055 | 0.153 | 0.153 |
Brugia malayi | Endoplasmin precursor | 0.007 | 0.2336 | 0.3558 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0846 | 0.362 |
Leishmania major | heat shock protein 83-1 | 0.007 | 0.2336 | 1 |
Trichomonas vaginalis | endoplasmin, putative | 0.0043 | 0.0806 | 0.345 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0055 | 0.1515 | 0.2308 |
Trypanosoma brucei | heat shock protein, putative | 0.007 | 0.2336 | 1 |
Echinococcus multilocularis | endoplasmin | 0.0055 | 0.153 | 0.153 |
Echinococcus granulosus | heat shock protein heat shock protein 90 alpha | 0.0055 | 0.153 | 0.153 |
Wolbachia endosymbiont of Brugia malayi | heat shock protein 90 | 0.0055 | 0.153 | 0.5 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.1515 | 0.1515 |
Plasmodium falciparum | heat shock protein 90 | 0.007 | 0.2336 | 1 |
Trypanosoma brucei | heat shock protein, putative | 0.007 | 0.2336 | 1 |
Leishmania major | heat shock protein 83-1 | 0.007 | 0.2336 | 1 |
Schistosoma mansoni | heat shock protein | 0.007 | 0.2336 | 0.2336 |
Leishmania major | heat shock protein 83-1 | 0.007 | 0.2336 | 1 |
Trypanosoma brucei | heat shock protein, putative | 0.007 | 0.2336 | 1 |
Plasmodium vivax | endoplasmin, putative | 0.007 | 0.2336 | 1 |
Leishmania major | heat shock protein 83-1 | 0.007 | 0.2336 | 1 |
Leishmania major | heat shock protein 83-1 | 0.007 | 0.2336 | 1 |
Entamoeba histolytica | heat shock protein 90, putative | 0.007 | 0.2336 | 1 |
Echinococcus granulosus | heat shock protein | 0.007 | 0.2336 | 0.2336 |
Echinococcus granulosus | endoplasmin | 0.0055 | 0.153 | 0.153 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0043 | 0.0846 | 0.0846 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.1515 | 0.1515 |
Trypanosoma cruzi | heat shock protein 85, putative | 0.007 | 0.2336 | 1 |
Leishmania major | heat shock protein 83-1 | 0.007 | 0.2336 | 1 |
Echinococcus multilocularis | heat shock protein 90 | 0.0055 | 0.153 | 0.153 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.1515 | 0.1515 |
Treponema pallidum | heat shock protein 90 | 0.0055 | 0.153 | 0.5 |
Brugia malayi | MH2 domain containing protein | 0.0144 | 0.6566 | 1 |
Trypanosoma brucei | heat shock protein 90, putative | 0.007 | 0.2336 | 1 |
Trichomonas vaginalis | heat shock protein, putative | 0.0055 | 0.153 | 0.655 |
Leishmania major | heat shock protein 83-1 | 0.007 | 0.2336 | 1 |
Giardia lamblia | Heat shock protein HSP 90-alpha | 0.007 | 0.2336 | 1 |
Trichomonas vaginalis | heat shock protein, putative | 0.0043 | 0.0806 | 0.345 |
Brugia malayi | heat shock protein 90 | 0.007 | 0.2336 | 0.3558 |
Toxoplasma gondii | heat shock protein 90, putative | 0.007 | 0.2336 | 1 |
Leishmania major | heat shock protein 83-1 | 0.007 | 0.2336 | 1 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0043 | 0.0846 | 0.0846 |
Schistosoma mansoni | heat shock protein | 0.007 | 0.2336 | 0.2336 |
Echinococcus multilocularis | heat shock protein | 0.007 | 0.2336 | 0.2336 |
Leishmania major | heat shock protein 83-1 | 0.007 | 0.2336 | 1 |
Leishmania major | heat shock protein 83-1 | 0.007 | 0.2336 | 1 |
Trypanosoma cruzi | heat shock protein 90, putative | 0.0055 | 0.153 | 0.655 |
Mycobacterium tuberculosis | Probable chaperone protein HtpG (heat shock protein) (HSP90 family protein) (high temperature protein G) | 0.0055 | 0.153 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0846 | 0.362 |
Brugia malayi | hypothetical protein | 0.0043 | 0.0846 | 0.1288 |
Leishmania major | lipophosphoglycan biosynthetic protein, putative,heat shock protein 90, putative,glucose regulated protein 94, putative | 0.0055 | 0.153 | 0.655 |
Leishmania major | heat shock protein 83-1 | 0.007 | 0.2336 | 1 |
Mycobacterium ulcerans | heat shock protein 90 | 0.0055 | 0.153 | 0.5 |
Echinococcus granulosus | heat shock protein 90 | 0.007 | 0.2336 | 0.2336 |
Trichomonas vaginalis | heat shock protein, putative | 0.0055 | 0.153 | 0.655 |
Trypanosoma cruzi | heat shock protein 85, putative | 0.0055 | 0.153 | 0.655 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.1515 | 0.1515 |
Trypanosoma brucei | heat shock protein, putative | 0.007 | 0.2336 | 1 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0043 | 0.0846 | 0.0846 |
Trypanosoma brucei | heat shock protein, putative | 0.007 | 0.2336 | 1 |
Leishmania major | heat shock protein 83-1 | 0.007 | 0.2336 | 1 |
Plasmodium falciparum | endoplasmin, putative | 0.0043 | 0.0806 | 0.345 |
Trichomonas vaginalis | heat shock protein, putative | 0.0055 | 0.153 | 0.655 |
Trypanosoma brucei | heat shock protein, putative | 0.007 | 0.2336 | 1 |
Leishmania major | heat shock protein 83-1 | 0.007 | 0.2336 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.1515 | 0.1515 |
Loa Loa (eye worm) | heat shock protein 90 | 0.007 | 0.2336 | 0.3558 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0846 | 0.362 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 0.6566 | 1 |
Trypanosoma cruzi | heat shock protein 90, putative | 0.007 | 0.2336 | 1 |
Leishmania major | heat shock protein 83-1 | 0.007 | 0.2336 | 1 |
Echinococcus multilocularis | heat shock protein 90 | 0.007 | 0.2336 | 0.2336 |
Leishmania major | heat shock protein 83-1 | 0.007 | 0.2336 | 1 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0055 | 0.1515 | 0.2308 |
Leishmania major | heat shock protein 83-1 | 0.007 | 0.2336 | 1 |
Trypanosoma brucei | Heat shock protein 83, putative | 0.007 | 0.2336 | 1 |
Leishmania major | heat shock protein 83-1 | 0.007 | 0.2336 | 1 |
Trypanosoma cruzi | heat shock protein 90, putative | 0.0041 | 0.0714 | 0.3058 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 1.8356 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | 5.8048 uM | PubChem BioAssay. Nrf2 qHTS screen for inhibitors: Nrf2 A549 ARE-Fluc Confirmation Assay for Hit Validation. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 8.9125 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | 9.285 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 11.2202 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 12.5893 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 16.3601 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 20.5962 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 25.1189 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PubChem BioAssay. qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 29.081 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493106, AID493143] | ChEMBL. | No reference |
Potency (functional) | 32.6294 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (binding) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Vif-A3F Interactions: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PubChem BioAssay. qHTS for Inhibitors of Vif-A3G Interactions: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Eta. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588636] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 100 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | ||
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.